Sanofi and German drugmaker Boehringer Ingelheim confirmed ... 01/10 …
Ipsen
Some investors have expressed frustration at Sanofi's failure to land a big deal ... of Actelion for a Swiss listing will be distributed to Actelion shareholders as a stock dividend prior to settlement of the tender offer, it said.
Sanofi Lost
After all, isn't that the failed politician's stock and trade? Christie spent much of his early ... "I hope it's one of the things I'll have a chance to …
Chris Christie
All of the foregoing was an obvious breath of fresh air at Sanofi at the time, but it now looks as if the French board has had enough. Bernstein analyst Tim Anderson, the dean of the pharma stock investment community, …
Chris Viehbacher
Sanofi (NYSE:SNY)’s share price was down 1% during mid-day trading on Tuesday . The company traded as low as $38.89 and last traded at $39.02, with a volume of 4,990,551 shares changing hands. The stock had …
Who will be the first to produce and sell a vaccine against the zika virus? Zika already affects 1.5 million people in Brazil. Sanofi SA (ADR) (NYSE:SNY) has the lead in the global race for the zika vaccine. The zika vaccine …
Zika virus
SNY). The company has seen its revenue and profits flatline over the last few years, causing its stock to follow suit. Shares of Sanofi have badly trailed both the S&P 500 and the healthcare sector in general, as judged by …
The Motley Fool
Shares of Sanofi SA (ADR) (SNY) continue their downward journey since Chris Viehbacher was ousted from his position as CEO late October by the company’s board of directors in the coup led by Chairman Serge …
This method discovered several great candidates for value-oriented investors, but today let's focus on Sanofi ( …